MyAverix Finance
HK · Healthcare
Sinopharm Group Co Ltd (1099)
Medical Distribution
Sinopharm Group Co Ltd (1099) is listed on HK in the Healthcare sector. Industry: Medical Distribution. As of 2026-05-21, reported market cap is $55.33B, P/E ratio is 6.72, net margin is 1.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1099
Sinopharm Group Co Ltd (1099) — FAQ
What is Sinopharm Group Co Ltd's market cap?
Sinopharm Group Co Ltd (1099) has a reported market cap of $55.33B (data as of 2026-05-21).
What is 1099's P/E ratio?
The price-to-earnings (P/E) ratio for Sinopharm Group Co Ltd (1099) is 6.72 (data as of 2026-05-21).
Does Sinopharm Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Sinopharm Group Co Ltd (1099). Check the MyAverix Finance app for the latest dividend data.
What sector is Sinopharm Group Co Ltd in?
Sinopharm Group Co Ltd (1099) is classified in the Healthcare sector (Medical Distribution industry).
What exchange is 1099 listed on?
1099 is listed on HK.
What is Sinopharm Group Co Ltd's net margin?
Sinopharm Group Co Ltd (1099) reports a net margin of 1.2% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.